Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study.

Sci Rep · 2020 · PMC7033169 · PMID 32080265

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

showed a trendP = 0.076so close (0.05 < p ≤ 0.1)

As indicated in Table 3 , most of the statin used showed a trend of a low risk of PH except lovastatin (aHR: 1.63, 95% CI: 0.95–2.79; P = 0.076) Among all of those being used, pravastatin had the lowest aHR and appeared to significantly reduce the risk of PH by 56% (aHR: 0.44, 95% CI: 0.23–0.86; P = 0.016).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.